Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Clinical trial NCT07572383 · RECRUITING

Trial details

NCT number: NCT07572383
Sponsor: Peter Caravan
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Interstitial Lung Disease Pulmonary Fibrosis

Start date: 2026-05-14
Primary completion: 2028-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.